|
|
Nventa Biopharmaceuticals Corporation - Company Profile Snapshot
| Company Profile: |
Nventa Biopharmaceuticals Corporation |
| Ticker: |
NVN |
| Exchanges: |
TOR |
| 2007 Sales: |
584,780 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
USA |
| Employees: |
27 |
Business Description
Nventa Biopharmaceuticals Corporation. The Group's principal activity is to discover, develop and commercialize innovative stress protein-based immunotherapeutics, also known as therapeutic vaccines, which are used for the treatment of infectious diseases and cancers. The Group uses a specific and unique class of proteins, called stress proteins, to regulate immune responses for therapeutic applications. The Group has market for its products in the United States, Canada and other Countries.
|
Not the Report you are looking for? Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
